GlassScriptPhysician profile
Elana Gersten
NPI 1851868517
$6,170.92
in general payments reported to CMS, 2019-2025
31 companies · $216 in 2025
The $216 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $152 · 2022: $258 · 2023: $2,547 · 2024: $2,999 · 2025: $216.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,662 · Education: $99.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,662.25 |
| Education | $99.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $3,307.51 | 2021-2024 | |
| Amgen INC. | $511.66 | 2022-2024 | Enbrel, Tavneos, Otezla |
| Glaxosmithkline, LLC. | $340.05 | 2023-2025 | Benlysta |
| Astrazeneca Pharmaceuticals LP | $293.55 | 2023-2024 | Saphnelo |
| Janssen Biotech, INC. | $214.21 | 2022-2024 | Tremfya, Simponi Aria, Stelara |
| Pfizer INC. | $184.78 | 2023-2025 | |
| Ucb, INC. | $138.82 | 2022-2024 | Cimzia |
| Aurinia Pharma U.S., INC. | $117.44 | 2023 | Lupkynis |
| Ani Pharmaceuticals, INC. | $108.45 | 2023-2024 | Purified Cortrophin Gel |
| Radius Health, INC. | $100.20 | 2023-2024 | Tymlos |
| Sanofi-Aventis U.S. LLC | $99.00 | 2024 | |
| Lilly USA, LLC | $97.34 | 2023-2024 | Taltz |
| Emd Serono, INC. | $78.95 | 2021 | |
| Horizon Therapeutics Plc | $78.93 | 2023 | Uplizna, Krystexxa |
| Zoll Respicardia, INC. | $70.07 | 2025 | Remede System |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $64.46 | 2022-2024 | Cyltezo |
| Medtronic, INC. | $54.77 | 2025 | Percept PC Brainsense |
| Mallinckrodt Hospital Products INC. | $37.57 | 2024 | Acthar |
| Novartis Pharmaceuticals Corporation | $34.78 | 2024 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $31.69 | 2024-2025 | Xifaxan |
| Alexion Pharmaceuticals, INC. | $26.89 | 2023 | |
| Corcept Therapeutics | $26.12 | 2024 | Korlym |
| Novo Nordisk INC | $21.25 | 2025 | Wegovy |
| Tersera Therapeutics LLC | $21.02 | 2023 | Quzyttir |
| Takeda Pharmaceuticals U.S.A., INC. | $20.03 | 2023 | Vpriv |
| Cipher Pharmaceuticals US LLC | $16.72 | 2025 | Natroba, Spinosad |
| Bayer Healthcare Pharmaceuticals INC. | $16.17 | 2024 | |
| Sobi, INC | $16.10 | 2023 | |
| Organon LLC | $15.51 | 2023-2024 | Renflexis |
| Genentech USA, INC. | $14.73 | 2023 | Rituxan, Actemra |
| Alvogen INC | $12.15 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Elana Gersten listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.